Načítá se...
Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
BACKGROUND: Standardized and sensitive assays for Epstein Barr Virus (EBV) are needed to define universal cutoff for treatment initiation in allogeneic hematopoietic stem cells transplant recipients. In a context of accreditation and the availability of EBV international standard, we evaluated the A...
Uloženo v:
| Vydáno v: | Virol J |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6998838/ https://ncbi.nlm.nih.gov/pubmed/32014036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-020-1285-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|